Intra-Cellular Therapies Inc. buy BiotechBee
Start price
19.02.24
/
70%
€69.40
Target price
30.09.25
€85.00
Performance (%)
-2.74%
Price
12:52
€67.50
Summary
This prediction is currently active. With a performance of -2.74%, the BUY prediction for Intra-Cellular Therapies Inc. by BiotechBee is down slightly. This prediction currently runs until 30.09.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intra-Cellular Therapies Inc. | 1.471% | 1.471% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
According to BiotechBee what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Stopped prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€58.60
24.06.23
24.06.23
€90.00
30.06.26
30.06.26
18.43%
19.02.24
19.02.24
Could be very worthwhile Investment >20% year
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.49
23.09.22
23.09.22
€80.00
31.07.25
31.07.25
28.12%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year